Overview
Nina Milosavljevic practices practicing medicine in Manchester, United Kingdom.
Ms. Milosavljevic is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Ganglion Cyst and Late-Onset Retinal Degeneration.
She is actively involved in clinical research, co-authoring 23 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nina Milosavljevic
Is Nina Milosavljevic a top-rated expert for Ganglion Cyst?
MediFind is an objective health platform that identifies experts based on real-world data. Nina Milosavljevic is classified as an Distinguished expert for Ganglion Cyst, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nina Milosavljevic participate in research or clinical trials?
Yes. Nina Milosavljevic has published 23 articles and abstracts on conditions like Ganglion Cyst. You can view a list of Nina Milosavljevic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ganglion CystMs. Milosavljevic isDistinguished. Learn about Ganglion Cyst.
- Experienced
- Late-Onset Retinal DegenerationMs. Milosavljevic isExperienced. Learn about Late-Onset Retinal Degeneration.